iWriteGigs

Fresh Grad Lands Job as Real Estate Agent With Help from Professional Writers

People go to websites to get the information they desperately need.  They could be looking for an answer to a nagging question.  They might be looking for help in completing an important task.  For recent graduates, they might be looking for ways on how to prepare a comprehensive resume that can capture the attention of the hiring manager

Manush is a recent graduate from a prestigious university in California who is looking for a job opportunity as a real estate agent.  While he already has samples provided by his friends, he still feels something lacking in his resume.  Specifically, the he believes that his professional objective statement lacks focus and clarity. 

Thus, he sought our assistance in improving editing and proofreading his resume. 

In revising his resume, iwritegigs highlighted his soft skills such as his communication skills, ability to negotiate, patience and tactfulness.  In the professional experience part, our team added some skills that are aligned with the position he is applying for.

When he was chosen for the real estate agent position, he sent us this thank you note:

“Kudos to the team for a job well done.  I am sincerely appreciative of the time and effort you gave on my resume.  You did not only help me land the job I had always been dreaming of but you also made me realize how important adding those specific keywords to my resume!  Cheers!

Manush’s story shows the importance of using powerful keywords to his resume in landing the job he wanted.

Mastery EAQ Ch. 26

Navigation   » List of Schools  »  International College of Health Sciences  »  Nursing  »  Nursing 1141- Pharmacology  »  Fall 2022  »  Mastery EAQ Ch. 26

Need help with your exam preparation?

Below are the questions for the exam with the choices of answers:

Question #1
A  The dose will be increased.
B  The medication will be stopped.
C  The dose will be decreased.
D  The dose will be unchanged.
Question #2
A  Not a candidate for fondaparinux based on both an insufficient creatinine clearance and an inadequate body weight
B  Is a candidate for fondaparinux based on a sufficient creatinine clearance and adequate body weight
C  Not a candidate for fondaparinux based on an insufficient creatinine clearance
D  Is a candidate for fondaparinux based on sufficient creatinine clearance and after body weight attains an adequate level
Question #4
A  Significantly decreased
B  Inadequate to evaluate treatment
C  Within normal limits
D  Significantly elevated
Question #5
A  Administer prescribed vitamin K if bruising is observed.
B  Monitor liver enzymes.
C  Assess for dysrhythmias.
D  Stop the medication if the systolic blood pressure drops below 110 mm Hg.
Question #6
A  Administering the medication when convenient
B  Administering the medication intramuscularly in the vastus lateralis
C  Massaging the site after the injection
D  Checking if the patient’s prescription contains enoxaparin
Question #7
A  “I take ginkgo supplements for memory enhancement.”
B  “I do not take aspirin for pain relief.”
C  “I refrain from drinking coffee and citrus fruit juices daily.”
D  “I eat 1 cup of green leafy vegetables daily.”
Question #8
A  “I get up and walk around at least once an hour.”
B  “I never sit with my legs crossed at the knees.”
C  “I’ve been on prolonged bed rest.”
D  “I avoid tight-fitting stockings or leggings.”
Question #11
A  Heart rate, Hemoglobin, Blood pressure
B  Hemoglobin, Platelet count, Activated partial thromboplastin time (aPTT)
C  Platelet count, Heart rate, Blood pressure
D  Activated partial thromboplastin time (aPTT), Blood pressure, Heart rate
Question #12
A  “I will take the medication with food.”
B  “I will place the pills in an organizer for easy use.”
C  “I will use the medication within 60 days after it is opened.”
D  “I will store the bottle in a dry place.”
Question #13
A  Creatinine clearance of 25 mL/min
B  Diagnosis of diabetes mellitus
C  Platelet count of 80,000/mm3
D  Loss of 10 pounds
Question #14
A  The dosage of the warfarin will be increased by half.
B  The dosage of the amiodarone will be increased by half.
C  The dosage of the warfarin will be decreased by half.
D  The dosage of the amiodarone will be decreased by half.
Question #15
A  Continue to administer cimetidine with each dose of warfarin.
B  Monitor the patient for decreased action of the anticoagulant.
C  Monitor the patient for increased action of the anticoagulant.
D  Instruct the patient to notify the nurse if he or she begins to experience discomfort.
Question #16
A  Gastrointestinal bleed
B  Peptic ulcer disease
C  Severe chest pain for the past 2 hours
D  Local thrombosis from a peripheral intravenous line
Question #17
A  Stop the medication.
B  Notify the health care provider immediately.
C  Monitor the patient and check the therapeutic range.
D  Increase the dose of heparin.
Question #18
A  Within the expected target therapeutic level of anticoagulation
B  Cannot be interpreted without knowing the prothrombin time and international normalized ratio
C  Outside the expected target therapeutic level of anticoagulation; it is too high
D  Outside the expected target therapeutic level of anticoagulation; it is too low
Question #19
A  Hemoglobin level: 11 g/dL
B  Prothrombin time: 13 sec
C  Platelet count: 100,000/mm3
D  Leukocyte count: 3000 cells/mm3
Question #20
A  Peptic ulcer disease, Chronic kidney disease
B  Atrial fibrillation, History of myocardial infarction
C  History of myocardial infarction, Chronic obstructive pulmonary disease
D  Chronic obstructive pulmonary disease, Atrial fibrillation
Question #21
A  Potassium level of 3.5 mEq/L
B  Activated partial thromboplastin time (aPTT) of 37 seconds
C  International normalized ratio (INR) of 1
D  Platelet count of 95,000/mm3
Question #22
A  The prothrombin time and activated partial thromboplastin time (aPTT) value are needed to interpret the finding.
B  Outside the expected target therapeutic level of anticoagulation; it is too high
C  Within the expected target therapeutic level of anticoagulation
D  Outside the expected target therapeutic level of anticoagulation; it is too low
Question #23
A  “Refrigerate and keep away from direct sunlight.”
B  “Discard the drug within 21 days of opening the original container.”
C  “Remove from the original package and place in aluminum foil.”
D  “Store the drug with the desiccant-drying agent in the packing cap.”
Question #25
A  Ensure that a loading dose was initially administered when beginning
B  Have protamine sulfate readily available at all times.
C  Monitor the patient’s laboratory values correctly.
D  Teach the patient about dietary restrictions while on the medication.
Question #26
A  Stop the intravenous (IV) drip.
B  Wait for the INR to decrease.
C  Administer vitamin K1 (phytonadione) IV.
D  Administer protamine sulfate IV.
Question #27
A  Dissolution of the clot that caused the heart attack
B  Reversal of damage from the infarction
C  A quick decrease in pain
D  Prevention of new clots from forming
Question #28
A  “I should follow a low-cholesterol diet during the therapy.”
B  “I should not use any acetaminophen during the therapy.”
C  “I should refrain from eating broccoli during the therapy.”
D  “I should take oral contraceptives during the therapy.”
Question #29
A  “I should use a soft toothbrush for dental hygiene.”
B  “I should keep taking ibuprofen for my arthritis.”
C  “I will double my dose if I forget to take it the day before.”
D  “I should decrease the dose if I start bruising easily.”
Question #30
A  “You should ask your doctor why dalteparin was ordered instead of regular heparin.”
B  “The only difference is that regular heparin dosing is based on the patient’s weight.”
C  “Dalteparin is a low-molecular-weight heparin that is more predictable in its effect and has a lower risk of bleeding.”
D  “There is no real difference; dalteparin is interchangeable with regular heparin.”
Question #31
A  Rub the administration site after injecting.
B  Draw up the medication in a syringe with a 22-gauge, 1.5-inch needle.
C  Administer the medication into subcutaneous tissue of the abdomen.
D  Utilize the Z-track method to inject the medication.
Question #32
A  “I will avoid contact sports.”
B  “I will contact my health care provider if I develop excessive bruising.”
C  “I will take my medication at the same time each day.”
D  “I will increase dark green leafy vegetables in my diet.”
Question #34
A  Aspirin daily (i.e., 81 mg)
B  Vitamin K daily
C  Warfarin daily
D  Recombinant factors
Question #35
A  Acute unstable angina
B  Transient ischemic attack
C  Vitamin K deficiency
D  Peripheral vascular disease
Question #36
A  Enoxaparin intramuscularly
B  Dabigatran orally
C  Warfarin orally
D  Heparin subcutaneously
Question #37
A  Ingestion of acetaminophen
B  Over-the-counter medications
C  Urine culture
D  Platelet level
Question #40
A  Blood urea nitrogen (BUN) level of 12 mg/dL
B  International normalized ratio (INR) of 1.0
C  Activated partial thromboplastin time (aPTT) of 120 seconds
D  Platelet count of 150,000 mm3
Question #41
A  Creatinine clearance value of 40 mL/min
B  Platelet count of 75,000 cell/μL
C  Hemoglobin level of 16.5 g/dL
D  Fasting blood glucose level of 95 mg/dL
Question #42
A  Vitamin K
B  Antithrombin III
C  Thrombin
D  Factor Xa
Question #43
A  Alteplase
B  Aminocaproic acid
C  Desmopressin
D  Tranexamic acid
Question #44
A  Antifibrinolytic
B  Thrombolytic
C  Anticoagulant
D  Antiplatelet
Question #45
A  Acute myocardial infarction
B  Heart failure
C  Coronary artery disease
D  Cardiomyopathy
Question #47
A  Fondaparinux
B  Dabigatran
C  Enoxaparin
D  Argatroban
Question #48
A  Selective factor Xa inhibitors
B  Warfarin
C  Heparins
D  Direct thrombin inhibitors
Question #49
A  Anticoagulants alter platelet function.
B  Anticoagulants dissolve clots.
C  Anticoagulants prevent clots from forming.
D  Anticoagulants interfere with drug metabolism.
Question #50
A  Antiplatelet
B  Antifibrinolytic
C  Thrombolytic
D  Anticoagulant
Question #51
A  Medication reaction
B  Anxiety
C  Fatigue from walking with pain
D  Embolus to the lungs
Question #52
A  Administering vitamin K1
B  Administering protamine sulfate
C  Infusing 50 mL of warfarin sodium
D  Increasing the dose of enoxaparin